Mercer Global Advisors
ARKG icon

Mercer Global Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Mercer Global Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,343
Closed -$271K – 3222
2025
Q4 		$271K Sell
9,343
-129
-1% -$3.87K ﹤0.01% 2314
2025
Q3 		$263K Buy
9,472
+41
+0.4% +$1.04K ﹤0.01% 2188
2025
Q2 		$230K Sell
9,431
-902
-9% -$19.8K ﹤0.01% 2013
2025
Q1 		$215K Sell
10,333
-745
-7% -$18.7K ﹤0.01% 1933
2024
Q4 		$261K Sell
11,078
-3,649
-25% -$89.8K ﹤0.01% 1829
2024
Q3 		$358K Sell
14,727
-14,216
-49% -$362K ﹤0.01% 1530
2024
Q2 		$888K Buy
28,943
+26,053
+901% +$657K ﹤0.01% 1019
2024
Q1 		$453K Buy
+2,890
New +$86.9K ﹤0.01% 1332
2023
Q3 		– Sell
-7,856
Closed -$268K – 1955
2023
Q2 		$268K Buy
+7,856
New +$247K ﹤0.01% 1574
2023
Q1 		– Sell
-6,992
Closed -$207K – 1936
2022
Q4 		$207K Sell
6,992
-1,641
-19% -$52.1K ﹤0.01% 1696
2022
Q3 		$284K Sell
8,633
-3,623
-30% -$133K ﹤0.01% 1441
2022
Q2 		$386K Sell
12,256
-1,700
-12% -$59.4K ﹤0.01% 1291
2022
Q1 		$641K Sell
13,956
-204
-1% -$9.73K ﹤0.01% 1115
2021
Q4 		$867K Sell
14,160
-1,313
-8% -$90.8K 0.01% 948
2021
Q3 		$1.16M Buy
15,473
+10,356
+202% +$869K 0.01% 792
2021
Q2 		$473K Buy
5,117
+1,682
+49% +$143K ﹤0.01% 1169
2021
Q1 		$305K Sell
3,435
-30,598
-90% -$3.04M ﹤0.01% 1303
2020
Q4 		$3.17M Sell
34,033
-302
-0.9% -$24.1K 0.04% 309
2020
Q3 		$1.79M Buy
+34,335
New +$2.01M 0.03% 410
2020
Q2 		– Sell
-40,375
Closed -$1.26M – 1019
2020
Q1 		$1.26M Buy
+40,375
New +$1.35M 0.03% 413

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Mercer Global Advisors's ARKG Position: Q1 2026 in Review

Mercer Global Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 9,343 shares — an estimated $271K sold.

Mercer Global Advisors first reported a position in ARKG in Q1 2020 and held it in 20 quarters. The position peaked at $3.17M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Mercer Global Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 9,343 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $271K.
  • Mercer Global Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 20 quarters.
  • Mercer Global Advisors's ARK Genomic Revolution ETF position peaked at $3.17M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.